Literature DB >> 25873402

MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.

Jie Chai1, Wei Dong, Chao Xie, Lin Wang, Da-Li Han, Shan Wang, Hong-Liang Guo, Zong-Li Zhang.   

Abstract

Chemoresistance of colon cancer cells to the chemotherapeutics is still a main obstacle in treatment of this malignancy. The microRNA (miRNA) mediated chemosensitivity regulation in colon cancer cells is still largely unknown. Here we constructed a fluorouracil (5-Fu) resistant SW480 cell line (SW480/5-Fu) and discovered that miRNA miR-494 was down-regulated in the drug resistant cells compared with the parental cells. miR-494 level was found to be correlated with 5-Fu sensitivity in colon cancer cells, and artificial alteration of miR-494 affects the sensitivity of colon cancer cell lines to 5-Fu. miR-494 also promoted apoptosis of colon cancer cells at present of 5-Fu. Importantly, as a regulatory enzyme in the 5-Fu catabolic pathway, DPYD was confirmed to be a direct target of miR-494 through the interaction of miR-494 and its binding site within DPYD 3' untranslated region (3'UTR). miR-494 also negatively regulated endogenous DPYD expression in SW480 cells. Overexpression or knockdown of DPYD could attenuate miR-494 mediated 5-Fu sensitivity regulation, suggesting the dependence of DPYD regulation in miR-494 activity. miR-494 inhibited SW480/5-Fu derived xenograft tumors growth in vivo at present of 5-Fu. Thus, we concluded that in colon cancer cells, tumor suppressor miR-494 enhanced 5-Fu sensitivity via regulation of DPYD expression.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  DPYD; chemoresistance; chemosensitivity; colon cancer; fluorouracil; miR-494; microRNA

Mesh:

Substances:

Year:  2015        PMID: 25873402     DOI: 10.1002/iub.1361

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  25 in total

Review 1.  Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.

Authors:  Padacherri Vethil Jishnu; Pradyumna Jayaram; Vaibhav Shukla; Vinay Koshy Varghese; Deeksha Pandey; Krishna Sharan; Sanjiban Chakrabarty; Kapaettu Satyamoorthy; Shama Prasada Kabekkodu
Journal:  Clin Exp Metastasis       Date:  2019-12-07       Impact factor: 5.150

Review 2.  The emerging role of noncoding RNAs in colorectal cancer chemoresistance.

Authors:  Ling Wei; Xingwu Wang; Liyan Lv; Yan Zheng; Nasha Zhang; Ming Yang
Journal:  Cell Oncol (Dordr)       Date:  2019-07-29       Impact factor: 6.730

Review 3.  MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.

Authors:  Xin Yu; Zheng Li; Jun Yu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-22       Impact factor: 6.831

Review 4.  MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.

Authors:  Fahima Danesh Pouya; Maria Gazouli; Yousef Rasmi; Dimitra Ioanna Lampropoulou; Mohadeseh Nemati
Journal:  Mol Biol Rep       Date:  2022-02-25       Impact factor: 2.742

5.  DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.

Authors:  Hiroyuki Kato; Aya Naiki-Ito; Shugo Suzuki; Shingo Inaguma; Masayuki Komura; Kenju Nakao; Taku Naiki; Kenta Kachi; Akihisa Kato; Yoichi Matsuo; Satoru Takahashi
Journal:  Carcinogenesis       Date:  2021-07-16       Impact factor: 4.944

6.  Aberrant expression of miR-153 is associated with overexpression of hypoxia-inducible factor-1α in refractory epilepsy.

Authors:  Yaohua Li; Cheng Huang; Peimin Feng; Yanping Jiang; Wei Wang; Dong Zhou; Lei Chen
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

7.  miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.

Authors:  Zhenyou Zou; Ruyi Zou; Dan Zong; Yonghong Shi; Jinyao Chen; Jie Huang; Jiahui Zhu; Liguan Chen; Xiaoyan Bao; Yuan Liu; Weihao Liu; Wenhui Huang; Jingsang Hu; Zhi Chen; Xiaojie Lao; Chaoqun Chen; Xiaoli Huang; Yao Lu; Xueyin Ni; Daoquan Fang; Dengqiang Wu; Shuangshuang Lu; Mingzhu Jiang; Chenyang Qiu; Yuya Wu; Qisha Qiu; Yanyuan Dong; Yangyang Su; Chenmin Zhao; Zhihe Zhong; Jing Cai; Yong Liang
Journal:  J Cell Mol Med       Date:  2017-04-14       Impact factor: 5.310

Review 8.  Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.

Authors:  Duncan Ayers; Jo Vandesompele
Journal:  Genes (Basel)       Date:  2017-03-03       Impact factor: 4.096

Review 9.  MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker.

Authors:  Ha Thi Nguyen; Salah Eddine Oussama Kacimi; Truc Ly Nguyen; Kamrul Hassan Suman; Roselyn Lemus-Martin; Humaira Saleem; Duy Ngoc Do
Journal:  Biology (Basel)       Date:  2021-05-08

10.  Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.

Authors:  I-Ping Yang; Hsiang-Lin Tsai; Zhi-Feng Miao; Ching-Wen Huang; Chao-Hung Kuo; Jeng-Yih Wu; Wen-Ming Wang; Suh-Hang Hank Juo; Jaw-Yuan Wang
Journal:  J Transl Med       Date:  2016-04-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.